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BACKGROUND: It has been suggested that the known poorer survival from cancer in the United Kingdom, compared with other
European countries, can be attributed to more advanced cancer stage at presentation. There is, therefore, a need to understand the
diagnostic process, and to ascertain the risk factors for increased time to presentation.
METHODS: We report the results from two worldwide systematic reviews of the literature on patient-mediated and practitioner-
mediated delays, identifying the factors that may influence these.
RESULTS: Across cancer sites, non-recognition of symptom seriousness is the main patient-mediated factor resulting in increased time
to presentation. There is strong evidence of an association between older age and patient delay for breast cancer, between lower
socio-economic status and delay for upper gastrointestinal and urological cancers and between lower education level and delay for
breast and colorectal cancers. Fear of cancer is a contributor to delayed presentation, while sanctioning of help seeking by others can
be a powerful mediator of reduced time to presentation. For practitioner delay, ‘misdiagnosis’ occurring either through treating
patients symptomatically or relating symptoms to a health problem other than cancer, was an important theme across cancer sites.
For some cancers, this could also be linked to inadequate patient examination, use of inappropriate tests or failing to follow-up
negative or inconclusive test results.
CONCLUSION: Having sought help for potential cancer symptoms, it is therefore important that practitioners recognise these
symptoms, and examine, investigate and refer appropriately.
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The possible influence of delays in diagnosis on survival and the
risk factors for delay in patients with cancer have been the subject
of considerable interest and controversy for many years. Survival
from cancer in the United Kingdom is poorer than that of other
European countries, and it has been suggested that this can be
attributed to more advanced disease stage at presentation (Cancer
Research UK, 2009). Consequently, there is a need to understand
the diagnostic process, and to ascertain risk factors related to
increased time to presentation and treatment. This is particularly
relevant in the context of primary care, where many patients
present with symptoms that may be indicative of cancer, but where
the outcome of the diagnostic process is the exclusion of cancer in
most cases. Furthermore, in countries with strong primary
healthcare systems, such as the United Kingdom, this is typically
the first point of contact for the majority of patients, making early
recognition of cancer symptoms even more pertinent.
Minimising time to diagnosis of cancer is dependent on patients
presenting with potential cancer symptoms and on primary care
practitioners responding appropriately to those symptoms, either
by arranging further investigation and/or referring for specialist
input. Delay can occur at three phases during the diagnostic
process: first, in the interval between the patient first noticing a
symptom and first consulting a doctor (often referred to as patient
delay), second, between first consultation and referral by a
practitioner (doctor or practitioner delay) and finally, between
referral and diagnosis (hospital or system delay) (Nichols et al, 1981).
In addition to outlining the various points during which
extraneous factors might adversely influence time to presentation
and referral, considering delay in these phases enables identifica-
tion of areas where interventions designed to reduce delay might
be targeted. However, before such interventions can be developed,
we need to better understand the factors that might lengthen or
shorten the time taken by patients to seek help for symptoms and
gain greater insights into how practitioners (usually in primary
care) respond to these symptoms. This topic is not easily amenable
to study by randomised trial, and as such, interpreting data
available from observational studies is essential to increasing our
understanding of the risk factors associated with delay and to
facilitating development of effective new strategies to reduce the
time involved. If longer delays do impact on survival, as has been
shown for breast cancer (Richards et al, 1999), such strategies
could save a significant number of lives.
MATERIALS AND METHODS
We report results from two systematic reviews of the world
literature. The first relates specifically to breast cancer (Ramirez
et al, 1999; Westcombe et al, 1999). The second covers other*Correspondence: Dr U Macleod; E-mail: u.macleod@clinmed.gla.ac.uk
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common cancers, namely colorectal, gynaecological, lung, upper
gastrointestinal and urological (Macdonald et al, 2004, 2006;
Mitchell et al, 2008). Both of these reviews described the extent of
patient-mediated and practitioner-mediated delays and identified
the factors that may cause such delays. The breast cancer literature
was reviewed from 1966 to 1997, and 23 studies met the inclusion
criteria; all were assessed as being of sufficient quality for inclusion
(Ramirez et al, 1999). Literature relating to the other cancers was
reviewed from 1970 to 2003, and 54 studies met the inclusion
criteria for colorectal cancer (45 sufficient quality), 16 for
gynaecological cancers (12 sufficient quality), 8 for lung cancer
(4 sufficient quality), 25 for upper gastrointestinal cancers
(18 sufficient quality) and 16 for urological cancers (11 sufficient
quality). Taken together. therefore, 142 papers were reviewed, of
which 113 were deemed of sufficient quality for inclusion in the
analyses. Detailed methods of each review are described
elsewhere, including the process of determining quality
(Westcombe et al, 1999; Macdonald et al, 2004). This paper reports
on and discusses risk factors for patient and primary care
practitioner delay. It combines and summarises earlier reported
results for breast, colorectal and upper gastrointestinal cancers,
with previously unreported results for gynaecological, lung and
urological cancers. Only risk factors derived from studies of
sufficient quality are presented; these are reported as either
increasing or reducing delay or as inconclusive, that is the
evidence was neither in support of the factor predominately
increasing nor reducing delay, and as such, the direction of
influence cannot be determined definitively.
Terminology
The term ‘delay’ in the cancer literature is used both to refer to time
delays and to denote advanced stage at presentation. More recently,
authors have tended to avoid use of the word delay, not only because
of this confusion, but also because the term implies an active
decision for inaction. However, the term is used extensively in the
literature and as such is impossible to avoid in a report of this
nature. Any reference to delay in this paper refers to time delay.
RESULTS
Risk factors for patient delay
Demographic factors Several demographic factors have been
studied in relation to their association with presentation for
cancer symptoms.
Age Older patient age was found to be a risk factor for delayed
presentation with symptoms of breast cancer (Ramirez et al, 1999),
but was unrelated to delay for colorectal cancer (Mitchell et al, 2008),
urological cancers (Thornhill et al, 1987; Samet et al, 1988; Mansson
et al, 1993; Risberg et al, 1996) and lung cancer (Worden and
Weisman, 1975; Mor et al, 1990; Risberg et al, 1996). There was no
conclusive evidence in relation to the influence of age on presentation
with symptoms of upper gastrointestinal (Macdonald et al, 2006) or
gynaecological cancers (Fruchter et al, 1980; Franceschi et al, 1983;
Fowler et al, 1984; Smith and Anderson, 1985; Dhamija et al, 1993;
Andersen et al, 1995; Coates et al, 1996; Risberg et al, 1996; Jones and
Joura, 1999; Goff et al, 2000) (Tables 1 and 3–5).
Gender Overall, men were found to delay longer than women in
presenting with bladder cancer (Mommsen et al, 1983; Mansson
et al, 1993; Risberg et al, 1996) and with other urological cancers
(Risberg et al, 1996). There was little evidence of any association
between sex and time to presentation for either upper or lower
gastrointestinal cancers (Macdonald et al, 2006; Mitchell et al,
2008) or for lung cancer (Worden and Weisman, 1975; Mor et al,
1990; Risberg et al, 1996; Bowen and Rayner, 2002).
Socio-economic status and education Lower socio-economic
status was associated with increased delay by patients presenting
with symptoms of upper gastrointestinal cancers (Macdonald et al,
2006) and by men with prostate cancer (Hackett et al, 1973; Samet
et al, 1988; Fitzpatrick et al, 1998). However, there was no overall
relationship between socio-economic status and delay for color-
ectal cancer (Mitchell et al, 2008), gynaecological cancers (Fruchter
et al, 1980; Fowler et al, 1984; Andersen et al, 1995; Coates et al,
1996; Goff et al, 2000) or lung cancer (Hackett et al, 1973; Worden
and Weisman, 1975; Mor et al, 1990). Similarly, although lower
educational attainment was associated with greater delay for
patients with breast (Ramirez et al, 1999) and colorectal cancers
(Mitchell et al, 2008), it was not related to presentation for any of
the urological (Mansson et al, 1993; Risberg et al, 1996) or
gynaecological cancers (Fruchter et al, 1980; Franceschi et al, 1983;
Dhamija et al, 1993; Andersen et al, 1995; Risberg et al, 1996) or
for lung cancer (Mor et al, 1990; Risberg et al, 1996).
Ethnicity Non-white ethnic origin was a risk factor for longer
delay in presenting with breast (Ramirez et al, 1999) and urological
cancers (bladder and prostate) (Samet et al, 1988; Prout et al,
2000), but non-white patients were found to have a shorter time to
presentation for stomach cancer (Macdonald et al, 2006). No
association was found between ethnicity and time to presentation
for gynaecological cancers (cervical and uterine) (Fruchter et al,
1980; Fowler et al, 1984; Coates et al, 1996).
Marital status Marital status or living with a partner was found
to be unrelated to presentation patterns for breast, gynaecological,
lung, upper gastrointestinal and urological cancers (Worden and
Weisman, 1975; Franceschi et al, 1983; Thornhill et al, 1987; Mor
et al, 1990; Mansson et al, 1993; Andersen et al, 1995; Fitzpatrick
et al, 1998; Ramirez et al, 1999; Macdonald et al, 2006). It was not
possible to draw a definitive conclusion in relation to its influence
on colorectal cancer (Mitchell et al, 2008).
Clinical factors
Symptom type The type of symptoms with which patients present
has a marked impact on presenting behaviour (Tables 1 and 3–5).
Women diagnosed with breast cancer were more likely to delay if
they had an atypical symptom, that is one that did not include a
breast lump (Ramirez et al, 1999). Across the cancer groups,
patients were typically less likely to delay if they experienced a
more serious symptom, such as pain, or an alarming symptom,
such as bleeding. This was found to be the case for upper
gastrointestinal cancers (Macdonald et al, 2006) and gynaecologi-
cal cancers (Smith and Anderson, 1985, 1987; Menon et al, 1991;
Coates et al, 1996; Goff et al, 2000) for pain associated with
colorectal cancer (Mitchell et al, 2008) and for bleeding associated
with urological cancers (bladder and prostate) (Mansson et al,
1993; Fitzpatrick et al, 1998; Ho et al, 1998). Conversely, pain was a
risk factor for increased delay in patients with urological cancers
(Hackett et al, 1973; Attard, 1985; Mansson et al, 1993; Fitzpatrick
et al, 1998), whereas the evidence for lung cancer was inconclusive
(Hackett et al, 1973; Worden and Weisman, 1975). Perhaps,
unsurprisingly, the onset of vague, non-specific, more common or
multiple symptoms was likely to increase delay (Andersen et al,
1995; Goff et al, 2000; Fitch et al, 2002; Mitchell et al, 2008). For the
majority of cancer groups studied, patients were more likely to
present when symptoms were, or became, more incapacitating and
impacted on daily life and activities (Hackett et al, 1973; Menon
et al, 1991; Andersen et al, 1995; Sanden et al, 2000; Macdonald
et al, 2006; Mitchell et al, 2008).
Co-morbidity The presence of co-existing morbidity was asso-
ciated with reduced delay in patients with upper gastrointestinal
cancers (Macdonald et al, 2006) and colorectal cancer (Mitchell
et al, 2008). However, this was found to be unrelated to presenting
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behaviour for lung cancer (Mor et al, 1990). There was evidence
that regular visits to medical practitioners, including attendance
for routine screening, was associated with shorter delay in patients
with gynaecological cancers (uterine and cervical) (Menon et al,
1991; Coates et al, 1996) and prostate cancer (Samet et al, 1988;
Fitzpatrick et al, 1998). The impact of a personal or family history
of cancer on help-seeking behaviour was investigated across
several sites, and in the main, there was no conclusive evidence as
to its impact. However, for patients with prostate cancer, having
had a previous cancer diagnosis (Samet et al, 1988) or having a
relative with cancer (Hackett et al, 1973; Fitzpatrick et al, 1998)
was typically associated with reduced time to presentation.
Furthermore, there was evidence of a positive relationship between
increased delay and having previously had a normal test result or
the condition diagnosed as benign (Fruchter et al, 1980; Smith and
Anderson, 1985).
Psychosocial factors
Awareness and interpretation of symptoms Symptom awareness,
and more particularly patients’ interpretation of symptoms, was a
commonly reported theme. Non-recognition of the seriousness of
symptoms, sometimes related to lack of knowledge about the
disease, was the predominant risk factor for delay reported across
all cancer sites (Worden and Weisman, 1975; Fruchter et al, 1980;
Bosl et al, 1981; Attard, 1985; Smith and Anderson, 1985, 1987;
Cochran et al, 1986; Mor et al, 1990; Menon et al, 1991; Mansson
et al, 1993; Andersen et al, 1995; Coates et al, 1996; Ajayi and
Adewole, 1998; Gascoigne et al, 1999; Ramirez et al, 1999; de
Nooijer et al, 2001; Bowen and Rayner, 2002; Fitch et al, 2002;
Khadra and Oakeshott, 2002; Kidanto et al, 2002; Macdonald et al,
2006; Mitchell et al, 2008) (Tables 1 and 3–5). Delay was often
related to patients adopting a ‘wait and see’ approach, denying or
redefining their symptoms in relation to benign disease or self-
diagnosing and self-medicating before presentation to a practi-
tioner (Macdonald et al, 2006; Mitchell et al, 2008).
Emotional response Concern related to recognition of a potential
cancer symptom was also important in the decision to present.
Fear that a symptom was indicative of cancer, or fear of
investigation, of treatment, or of powerlessness were also found
to be factors in increasing time to presentation for upper and lower
gastrointestinal cancers (Macdonald et al, 2006; Mitchell et al,
2008), urological cancers (Hackett et al, 1973; Fitzpatrick et al,
1998; Ho et al, 1998; de Nooijer et al, 2001; Sanden et al, 2000),
gynaecological cancers (Fruchter et al, 1980; Smith and Anderson,
1985, 1987) and lung cancer (Hackett et al, 1973; Worden and
Weisman, 1975; Mor et al, 1990). Similarly, embarrassment about
symptoms resulted in longer delay for patients with colorectal
(Mitchell et al, 2008) and urological cancers (testicular and
prostate) (Fitzpatrick et al, 1998; Gascoigne et al, 1999).
Support Social support and the availability of advice were
influential factors in patients’ decisions to present with cancer
symptoms. Patients with breast cancer, who did not disclose their
symptoms within a week to someone close to them, were more
likely to delay help seeking (Ramirez et al, 1999). For patients with
colorectal cancer, social networks were identified as a potentially
important factor in reducing delay, when patients either sought
advice from or made decisions based on the experience of others
(Mitchell et al, 2008). In keeping with this, lower levels of social
support were found to be associated with increased delay in
women with endometrial cancer (Cochran et al, 1986) (Table 1).
However, the availability of social support was unrelated to delay
for lung, upper gastrointestinal and urological cancers (Samet
et al, 1988; Mor et al, 1990; Bowen and Rayner, 2002; Sanden et al,
2000; Macdonald et al, 2006).
Risk factors for practitioner delay
Patient demographic factors There was some evidence relating to
the impact of certain patient characteristics on practitioners’
referral behaviour (Tables 2–5).
Age and gender Older patients were referred more quickly for
symptoms of breast, upper gastrointestinal and colorectal cancers
(Ramirez et al, 1999; Macdonald et al, 2006; Mitchell et al, 2008).
However, younger patients experienced less delay in referral when
presenting with symptoms related to one of the urological cancers
Table 1 Risk factors for patient-mediated delay
Risk factor Breast Upper GIa Colorectal Urob Gync Lung
Demographic
Age (older) m } ¼ ¼ } ¼
Sex (male) N/A ¼ ¼ m N/A ¼
Socio-economic status (lower) } m ¼ m ¼ ¼
Education level (lower) m } m ¼ ¼ ¼
Ethnicity (non-white origin) m k } m ¼ J
Marital status (married/co-habiting) ¼ ¼ } ¼ ¼ ¼
Clinical
Symptom type m m m m m }
Symptom – pain B k k m k }
Symptom – bleeding B k } k k J
Symptom impacts on daily life J k k k k k
Co-morbidity J k k J J ¼
Infrequent care seeking J J } m m J
Personal/family history of cancer J } } k J }
Psychosocial
Non-recognition of symptom seriousness m m m m m m
Fear J m m m m m
Embarrassment J J m m J J
Social support/advice k ¼ k ¼ k ¼
Abbreviation: GI¼ gastrointestinal. Key: m increases delay; k reduces delay; ¼ no impact on delay;} inconclusive evidence;J lacking evidence;B any non-lump symptom.
Risk factor included only if supported by studies providing strong or moderate levels of evidence (Sources: Ramirez et al, 1999; Macdonald et al, 2004, 2006; Mitchell et al, 2008).
aDuodenum, oesophagus, pancreas, small intestine, stomach. bBladder, kidney, prostate, testes. cCervix, endometrium, ovary, uterus, vagina, vulva.
Risk factors for delayed presentation of symptomatic cancer
U Macleod et al
S94
British Journal of Cancer (2009) 101(S2), S92 – S101 & 2009 Cancer Research UK
(Mansson et al, 1993; Risberg et al, 1996) or to lung cancer
(Risberg et al, 1996). There was no conclusive evidence on
the direction of effect for patient age and practitioner delay
for gynaecological cancers (Fruchter et al, 1980; Fowler et al,
1984; Risberg et al, 1996). Men with upper gastrointestinal
cancers (Macdonald et al, 2006) and urological cancer (bladder)
(Mommsen et al, 1983; Mansson et al, 1993) were less likely than
women to have experienced delayed referral, although the evidence
relating to colorectal cancer was inconclusive (Mitchell et al, 2008).
Socio-economic status, education and ethnicity Patients from
lower socio-economic groups experienced a shorter wait to referral
for upper gastrointestinal cancer (Macdonald et al, 2006), but
greater delay than more affluent patients in referral for colorectal
cancer (Mitchell et al, 2008). Although socio-economic status was
unrelated to referral for symptoms of gynaecological cancers
(Fowler et al, 1984; Goff et al, 2000), lower educational attainment
was associated with delayed referral in this group, as it was
for patients with symptoms of lung and urological cancers
(Risberg et al, 1996). There was little evidence on the influence
of ethnicity, although non-white women with breast cancer
experienced less practitioner delay (Ramirez et al, 1999), whereas
this was unrelated to referral for gynaecological cancer (cervical)
(Fowler et al, 1984).
Presenting symptom and medical history As was the case in
patient delay, presenting with a breast symptom other than a lump
was associated with greater delay by practitioners (Ramirez et al,
1999). Typically, pain as a presenting symptom resulted in shorter
time to referral for patients with upper gastrointestinal cancers
(Macdonald et al, 2006) and gynaecological cancer (ovarian) (Goff
et al, 2000; Fitch et al, 2002). This was also found to be the case for
bleeding in upper gastrointestinal cancers (Macdonald et al, 2006)
and urological cancer (bladder) (Mommsen et al, 1983; Mansson
et al, 1993). Patients with co-existing disease were likely to be
referred more quickly for symptoms of colorectal cancer (Mitchell
et al, 2008), but the evidence relating to upper gastrointestinal
cancers was inconclusive (Macdonald et al, 2006). However, time
to referral for colorectal cancer was increased for patients who
frequently consulted their general practitioner (Mitchell et al,
2008), and the involvement of multiple care providers resulted in
delay for patients with gynaecological cancer (ovarian) (Fowler
et al, 1984; Goff et al, 2000). Frequency of attendance was
unrelated to referral for upper gastrointestinal cancers (Macdonald
et al, 2006).
Practitioner response The most commonly identified themes
associated with delayed referral across the cancer sites related to
initial diagnosis and activity of the practitioner. Misdiagnosis,
occurring either through treating patients symptomatically or by
relating symptoms to a health problem other than cancer,
resulted in increased time to referral for breast, colorectal,
gynaecological, upper gastrointestinal and urological cancers (Bosl
et al, 1981; Attard, 1985; Gascoigne et al, 1999; Jones and Joura,
1999; Ramirez et al, 1999; Goff et al, 2000; Fitch et al, 2002;
Macdonald et al, 2006; Mitchell et al, 2008). Although there was
support for the existence of a similar pattern in relation to
diagnosis of lung cancer (Table 4), the evidence was of relatively
poor quality (Pereira et al, 1991; Silva et al, 1992; Bowen and
Rayner, 2002; Koyi et al, 2002). Failure to fully or adequately
examine patients, use of inappropriate or inadequate tests and
receiving or failing to follow-up inconclusive, negative or false
negative test results contributed to the delay (Fruchter et al, 1980;
Bosl et al, 1981; Hernes et al, 1996; Goff et al, 2000; Macdonald
et al, 2006; Mitchell et al, 2008). Similarly, prescribing treatment
for benign conditions, such as acid suppression in patients
subsequently diagnosed with upper gastrointestinal cancers
(Macdonald et al, 2006), or antibiotics in patients with testicular
cancer (Bosl et al, 1981) also increased time to referral. There is
some evidence to suggest that appropriate referral and use of
referral guidelines is associated with reduced delay for upper
gastrointestinal cancers (Macdonald et al, 2006) and colorectal
cancer (Mitchell et al, 2008).
DISCUSSION
Reasons for delay in presentation by patients with symptoms of
cancer and influences on time to referral by practitioners are
complex and multi-factorial according to the combined findings of
two systematic reviews of the literature on common cancers. The
predominant risk factor for patient delay is a lack of interpretation
by patients of the serious nature of their symptoms. Across the
common cancers, symptom type is predictive of delay in
presentation. If a symptom is atypical, or vague in nature, the
risk of delayed presentation can be increased. Conversely, if the
Table 2 Risk factors for practitioner-mediated delay
Risk factor Breast Upper GIa Colorectal Urob Gync Lung
Patient demographics
Age (older) k k k m } m
Sex (male) N/A k } k N/A J
Socio-economic status (lower) J k m J ¼ J
Education level (lower) J J J m m m
Ethnicity (non-white origin) k J J J ¼ J
Presenting symptom and history
Symptom – pain B k } J k J
Symptom – bleeding B k } k J J
Co-morbidity J } k J J J
Frequent care seeking/multiple providers J ¼ m J m J
Practitioner response
Initial misdiagnosis m m m m m J
Inadequate examination/inappropriate tests J m m m m J
Treatment for benign condition J m J m J J
Use of referral guidelines J k k J J J
Abbreviation: GI¼ gastrointestinal. Key: m increases delay; k reduces delay; ¼ no impact on delay;} inconclusive evidence;J lacking evidence;B any non-lump symptom.
Risk factor included only if supported by studies providing strong or moderate levels of evidence (Sources: Ramirez et al, 1999; Macdonald et al, 2004, 2006; Mitchell et al, 2008).
aDuodenum, oesophagus, pancreas, small intestine, stomach. bBladder, kidney, prostate, testes. cCervix, endometrium, ovary, uterus, vagina, vulva.
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Table 3 Risk factors associated with delay for gynaecological cancers
Author(s) Location Study type Participants Cancer site
Factors which
increase delay
Factors which
reduce delay
No impact on
delay Evidence
Patient-associated factors
Fruchter et al
(1980)
NY, USA Prospective
observational
97 patients Cervix Non-recognition of
symptom seriousness;
previous normal test
result; fear
Age; ethnicity;
education; income;
place of birth
Moderate
Franceschi et al
(1983)
Italy Prospective
observational
173 patients
(aged 33–84;
median 59)
Endometrium Age – younger; pre-
menopausal women
Increased patient
awarenessa
Marital status;
education; parity;
BMI; contraception
Strong
Fowler et al
(1984)
NC, USA Retrospective
observational
271 patients Cervix Age; ethnicity;
insurance cover
Moderate
Smith and
Anderson (1985)
IA, USA Prospective
observational
82 patients
(aged 20–54)
Ovary Non-recognition of
symptom seriousness;
re-appearance of
previous benign
condition; fear
Symptom type –
abdominal pain or
swelling, irregular
bleeding; age – older
Strong
Cochran et al
(1986)
CA, USA Prospective
observational
37 patients
(48 – 72;
median 64)
Endometrium Attributing symptoms
to menopause; marital
dissatisfaction; lower
social support
Recognition of symptom
seriousness (attributing
to cancer); longer time
since menopause
Moderate
Smith and
Anderson (1987)
IA, USA Prospective
observational
98 patients
(aged 20–54;
median 49)
Endometrium Non-recognition of
symptom seriousness;
fear
Symptom type –
irregular bleeding,
discharge, abdominal
pain
Strong
Menon et al
(1991)
India Observational 117 patients Cervix Non-recognition of
symptom seriousness;
symptom type –
irregular bleeding, vaginal
discharge; lack of
attendance for
check-ups
Symptom type – pus
discharge, continuous
bleeding
Moderate
Dhamija et al
(1993)
India Cross-sectional 1411 ever-married
women
Cervix Lack of patient
awarenessa
Age – younger;
education level – highera
Insufficient
Andersen et al
(1995)
OH, USA Prospective
observational
34 patients
(aged 24–75;
mean 50)
Endometrium,
vulva, ovary,
vagina
Age – older; innocuous
or diffuse symptoms;
attributing symptoms to
normal life circumstances
Symptom becomes
more prominent/serious
Marital status;
education;
employment; family
circumstances; religion
Strong
Coates et al
(1996)
GA, LA,
CA, USA
Prospective
observational
331 patients
(aged 20–79)
Uterus Infrequent care seeking;
income – lower; marital
status – divorced;
occupation – blue
collar/service; no health
insurance; smoker
Recognition of symptom
seriousness; age – older;
symptom type – vaginal
bleeding
Ethnicity Moderate
Risberg et al
(1996)
Norway Cross-sectional 252 cancer patients
(mean age 58; 52%
men, 48% women),
5% with
gynaecological
cancer
All Age; education level Strong
Ajayi and
Adewole (1998)
Nigeria Cross-sectional 254 women
(aged 20–65)
Cervix Lack of patient
awarenessa
Insufficient
Jones and Joura
(1999)
New
Zealand
Retrospective
observational
102 patients
(aged 36–94)
Vulva Lack of patient
awarenessa
Age Insufficient
Goff et al (2000) USA; Canada Observational 1725 patients
(aged 18–84;
median 52)
Ovary Ignoring symptoms;
multiple symptoms
Age – older Health insurance;
symptom type
Insufficient
Fitch et al (2002) Toronto,
Canada
Qualitative
interviews
18 women
(aged 35–73;
mean 53)
Ovary Non-recognition of
symptom seriousness;
symptom type – vague
Strong
Kidanto et al
(2002)
Tanzania Case – control 267 patients,
89 with cancer
(mean age 49);
178 controls
(mean age 46)
Cervix Non-recognition of
symptom seriousness;
lack of knowledge
Moderate
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symptom is more serious or alarming and includes a lump,
bleeding or pain, then the risk of delayed presentation is typically
reduced. Patients may fail to recognise or appreciate atypical or
vague symptoms, which may mediate delayed presentation. Where
symptoms are understood and thought to be serious, there is a
reduced time to presentation, and whatever the cancer site, the
catalyst for presentation is often when a symptom becomes
incapacitating or impacts on normal activities, rather than the
presence of the symptom alone. However, the difficulty is that
common cancer symptoms are often attributable to benign disease.
The complexity of this process can be illustrated by considering
breast cancer, where there is robust evidence that patients delay
less with the well-known symptom of lump, compared with the less
recognised non-lump symptoms, which result in greater delay.
This contrasts with the evidence for urological cancers, where pain
increases delay, perhaps as a result of symptoms being mis-
interpreted as being due to a benign cause such as cystitis. In other
cancers too, such as those of the gastrointestinal tract, potential
cancer symptoms can frequently have a benign interpretation.
Patient delays are also influenced by a range of demographic
and psychosocial factors. Taken together, lower socio-economic
status and education level are risk factors for delayed presentation
of several common cancers, but not for others. Similarly, non-
white ethnic origin impacts on delayed presentation for some, but
not all common cancers. Neither age nor gender is associated with
delayed presentation with the exception of breast cancer (older
age) and bladder cancer (male sex). Across the common cancers,
then demographic risk factors for patient delay seem inconsistent.
This may be a consequence of the fact that the cancers have not
been equally researched in terms of risk factors for delay. Although
the review of the literature for breast cancer was based on 23
studies deemed to be of adequate quality, and the upper and lower
gastrointestinal results were based on 18 and 45 studies,
respectively, only 11 urological, 12 gynaecological and 4 lung
cancer studies were of sufficient quality to be included in the
synthesis of evidence. Further, it is possible that some of the
factors we have described are not independent of each other; the
ways in which they may relate to each other are not clear.
General population surveys in the United Kingdom indicate a
widespread lack of awareness of the symptoms of cancer (Grunfeld
et al, 2002; McCaffery et al, 2003; Linsell et al, 2008; Robb et al,
2009). These low levels of symptom awareness may partly explain
why the type of symptom and recognition of the seriousness of
symptoms are consistent risk factors for delayed patient presenta-
tion. These surveys also suggest that cancer symptom awareness is
poorer among those who are less well educated, those with lower
socio-economic status and those from black and minority ethnic
groups (Wardle et al, 2001; Grunfeld et al, 2002; Robb et al, 2009).
Not only are levels of awareness of cancer symptoms low among
the general population, but so too is knowledge of the risk factors
for developing cancer. Equally, these surveys report that people
hold negative beliefs and attitudes about the benefits of seeking
medical help for cancer, which include fear, embarrassment,
reluctance to bother the general practitioner and nihilism about
cancer treatments (Grunfeld et al, 2002; Robb et al, 2009). These
barriers may explain the finding from our review that fear and
embarrassment are risk factors for patient delay.
Qualitative research with people diagnosed with cancer further
enhances the findings of such surveys. Reported barriers to early
help seeking are vague and mild symptoms, absence of pain or
lump, belief that the symptom will go away, intermittent
symptoms, lack of awareness of cancer risk and previous benign
diagnosis (Smith et al, 2005). Competing demands and priorities,
fears about cancer treatments and anxieties about ‘bothering the
doctor’ have also been identified as issues related to delayed
presentation in breast cancer (Burgess et al, 2001). Qualitative
interviews have enabled the identification of eventual triggers to
help seeking, such as worsening symptoms, new additional
symptoms, the presence of a symptom that is recognised as
serious or is affecting daily life and the influence of family and
Table 3 (Continued )
Author(s) Location Study type Participants Cancer site
Factors which
increase delay
Factors which
reduce delay
No impact on
delay Evidence
Practitioner-associated factors
Fruchter et al
(1980)
NY, USA Prospective
observational
97 women Cervix Inconclusive test results;
inadequate examination;
failure to follow-up
negative result; patient
age – younger
Moderate
Fowler et al (1984) NC, USA Retrospective
observational
271 patients Cervix Involvement of
several physicians
Age; ethnicity;
insurance cover
Moderate
Risberg et al (1996) Norway Cross-sectional 252 cancer patients
(mean age 58; 52%
men, 48% women),
5% with
gynaecological
cancer
All Patient age – younger;
patient education
level – higher
Strong
Jones and Joura
(1999)
New
Zealand
Retrospective
observational
102 patients
(aged 36–94)
Vulva Initial misdiagnosisa Insufficient
Goff et al (2000) USA; Canada Observational 1725 patients (aged
18 –84; median 52)
Ovary Multiple providers of
care; incomplete/
inappropriate
examination; initial
misdiagnosis; multiple
symptoms
Type of physician
initially seen; health
insurance; symptom
type
Insufficient
Fitch et al (2002) Canada Qualitative
interviews
18 women
(aged 35–73;
mean 53)
Ovary Symptom type – vague;
misinterpretation of
symptoms
Symptom type – pain Strong
Abbreviation: BMI¼ body mass index. aStudy infers findings.
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friends (Burgess et al, 2001; Smith et al, 2005), findings supported
by the evidence presented in this paper.
Overall, research into the risk factors for patient delay indicates
that presentation with cancer is not a straightforward or linear
process. Knowledge of symptoms and risk may be necessary, but
not sufficient to determine help seeking for cancer. People’s
attitudes, beliefs and social context clearly influence the process of
medical help seeking. To develop strategies to reduce patient
delays, the risk factors for delayed presentation need to be placed
into an explanatory framework. This aids understanding of the
complexities of the delay process and highlights where and how
interventions could be targeted. A framework for understanding
patient delay in breast cancer is described by Bish et al (2005). This
model incorporates symptom appraisal, attitudes towards help-
seeking and translating intentions to seek help into behaviour. It
draws on health psychology models, including self-regulation
theory (Leventhal et al, 1984), theory of planned behaviour (Ajzen,
1991) and implementation intentions (Gollwitzer, 1999). A similar
model (Andersen et al, 1995) has been suggested for other cancers.
Basing an intervention to promote behaviour change in an
explanatory framework informed by psychological theory and
empirical evidence increases the likelihood that it will be effective
(Bish et al, 2005; Serlachius and Sutton, 2009).
To impact on presentation with cancer symptoms, we need a
greater understanding of the psychological and sociological factors
influencing patients’ help-seeking behaviour. In addition, we need
to devise culturally sensitive strategies, not only to improve
awareness of cancer, but also to aid interpretation of symptom
seriousness by patients. Ideally, an intervention to reduce
delayed presentation of cancer would promote early help-seeking
Table 4 Risk factors associated with delay for lung cancer
Author(s) Location Study type Participants Cancer site
Factors which
increase delay
Factors which
reduce delay
No impact on
delay Evidence
Patient-associated factors
Hackett et al (1973) MA, USA Prospective
observational
563 patients (aged
17–91; mean 62; 46%
men, 54% women),
6% with lung cancer
Lung Symptom type – pain;
social class – lower;
procrastination; worry
over health; family
history
Worry; incapacitated
by symptoms;
acknowledgement of
cancer
Strong
Worden and
Weisman (1975)
MA, USA Prospective
observational
125 patients (aged
19–59, 38% men,
62% women), 18%
with lung cancer
Lung Non-recognition of
symptom seriousness;
denial; powerlessness;
cancer site – lung
compared with breast,
Hodgkin
Cancer site – lung
compared with
melanoma
Age; sex; marital
status; socio-economic
status; family history;
presenting symptoms
Strong
Mor et al (1990) RI, USA Prospective
observational
625 patients (aged
45–90; 31% men, 69%
women), 19% with
lung cancer
Lung Non-recognition of
symptom seriousness;
symptom type – nagging
cough; belief that
symptoms would ‘go
away’; fear of cancer
Age; sex; marital
status; education;
socio-economic status;
social support; co-
morbidity
Strong
Risberg et al (1996) Norway Cross-
sectional
252 cancer patients
(mean age 58; 52% men,
48% women), 16% with
lung cancer
Lung Cancer site – lung
compared with GI,
urological, Hodgkin;
sex – female
Age; education Strong
Bowen and Rayner
(2002)
England Prospective
observational
37 patients, 51% men
(aged 45–80; mean 65),
49% women (aged
44–90; mean 67)
Lung Non-recognition of
symptom seriousness;
lack of awareness of
symptoms
Sex – female; advice
from social network
Insufficient
Koyi et al (2002) Sweden Prospective
observational
134 patients, 63% men
(aged 48–90, mean 72);
37% women (aged
35–90, mean 70)
Lung Lack of awareness;
difficulty in accessing
primary carea
Insufficient
Practitioner-associated factors
(Pereira et al (1991)) Brazil Prospective
observational
100 patients Lung Lack of awareness;
inadequate testsa
Insufficient
(Silva et al (1992)) Brazil Prospective
observational
300 patients Lung Improved GP
awarenessa
Insufficient
Risberg et al (1996) Norway Cross-
sectional
252 cancer patients
(mean age 58: 52% men,
48% women), 16% with
lung cancer
Lung Patient age – younger;
patient education
level – higher
Strong
Bowen and Rayner
(2002)
England Prospective
observational
37 patients, 19 men
(mean age 65), 18
women (mean age 67)
Lung Lack of symptom
awareness
Insufficient
Koyi et al (2002) Sweden Prospective
observational
134 patients, 63% men
(aged 48–90, mean 72);
37% women (aged
35–90, mean 70)
Lung Lack of suspiciona Low threshold for
referrala
Insufficient
aStudy infers findings; (non-English language paper).
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Table 5 Risk factors associated with delay for urological cancers
Author(s) Location Study type Participants Cancer site
Factors which
increase delay
Factors which
reduce delay
No impact on
delay Evidence
Patient-associated factors
Hackett et al
(1973)
MA, USA Prospective
observational
563 patients (aged
17–91; mean 62,
46% men, 54%
women), 9% with
prostate cancer
Prostate Symptom type – pain;
social class – lower;
procrastination; worry
over health; family
history
Worry; incapacitated by
symptoms;
acknowledgement of
cancer
Strong
Bosl et al (1981) MN, USA Retrospective
observational
335 patients
(mean age 31)
Testicular Non-recognition of
symptom seriousness
Moderate
Mommsen et al
(1983)
Denmark Prospective
observational
212 patients
(mean age 66; 78%
men, 22% women)
Bladder Symptom type – cystitis Sex – female Moderate
Attard (1985) England Retrospective
observational
23 patients Testicular Non-recognition of
symptom seriousness;
symptom type – painless
Insufficient
Thornhill et al
(1987)
Ireland Retrospective
observational
217 patients Testicular Presence of atypical
symptoms; symptom
type – dragging
sensation
Improved patient
awarenessa
Age; marital status;
area of residence
Strong
Samet et al (1988) NM, USA Prospective
observational
800 patients, (aged
65–100, mean 72),
32% with prostate
cancer
Prostate Site – prostate
compared with breast
and colorectal; ethnicity
– white Hispanic
Previous cancer
diagnosis; regular check-
ups
Age; income;
availability of vehicle;
social support;
participation in
screening
Strong
Mansson et al
(1993)
Sweden Cross-sectional 343 patients (aged
27–94; 77% men,
23% women)
Bladder Non-recognition of
symptom seriousness
symptom type –
urgency, pain
Symptom type –
haematuria
Age; sex; education;
marital status
Strong
Hernes et al (1996) Norway Retrospective
observational
352 patients (aged
15–83, median 32)
Testicular Lack of patient
awarenessa
Cancer type – non-
seminoma
Insufficient
Risberg et al (1996) Norway Cross-sectional 252 cancer patients
(mean age 58; 52%
men, 48% women), 15%
with urological cancer
Testicular,
prostate,
bladder, kidney
Cancer site – kidney,
bladder, prostate
Cancer site – testicular;
sex – female
Age; education level Strong
Fitzpatrick et al
(1998)
Ireland Cross-sectional 280 randomly selected
men, (aged 40–69,
mean 53)
Prostate Lack of patient
awareness; social class –
lower; embarrassment;
fear of treatment
Living with female
partner; history of
urinary tract disease;
symptom type – pain,
bleeding; saw GP 41
in past year; having a
relative with cancer
Moderate
Ho et al (1998) Northern
Ireland
Prospective
observational
100 haematuria clinic
patients (aged 18 –97,
mean 57; 64% men,
36% women)
Bladder Fear of cancer; previous
haematuria
Improved patient
awarenessa
Insufficient
Gascoigne et al
(1999)
Wales Qualitative
interviews
11 patients and carers Testicular Non-recognition of
symptom seriousness;
embarrassment
Strong
Prout et al (2000) USA Prospective
observational
497 patients
(aged 20 –79)
Bladder Ethnicity – black Strong
Sanden et al (2000) Sweden Qualitative
interviews
21 patients
(aged 20 –49)
Testicular Symptom type –
intermittent symptoms;
adopting a ‘wait and see’
approach’; fear of cancer
diagnosis
Symptom impacting on
everyday activity; advice
from social network
Insufficient
de Nooijer et al
(2001)
The
Netherlands
Qualitative
interviews
23 patients (mean age
52; 43% men, 57%
women), 22% with
testicular cancer, 10 GPs
Testicular Non-recognition of
symptom seriousness;
fear of cancer
Fear of cancer; trust
in GP
Strong
Khadra and
Oakeshott (2002)
England Cross-sectional 202 men; (aged 18 –50,
mean 32)
Testicular Lack of patient
awarenessa
Insufficient
Practitioner-associated factors
Bosl et al (1981) MN, USA Retrospective
observational
335 patients
(mean age 31)
Testicular Lack of awareness; initial
misdiagnosis; inadequate
examination;
inappropriate treatment
Moderate
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behaviour by people with a high cancer risk, but would not
promote anxiety among those at low risk. It is important that
patients are neither made unnecessarily anxious, nor should
general practitioners be overburdened by consultations with ‘the
worried well’. The demographic risk factors for patient delay and
low cancer awareness suggest the population groups that we
should target with interventions to promote early presentation.
The evidence suggests a general focus on populations that are
socially deprived and less educated, as well as those from black and
minority ethnic groups. Interventions related to breast cancer
should be targeted at older women. However, further research is
needed to clarify relevant risk factors for delayed time to
presentation for some particularly under-researched cancers, such
as lung and prostate.
When people do present to their doctor with potential cancer
symptoms, timely investigation and onwards referral are clearly
important. The reviews reported here suggest that patients with
particular demographic profiles are likely to experience practi-
tioner delay, including, for some cancer sites, women and those
with lower educational attainment. There is also evidence that
vague and atypical symptoms are not only associated with patient
delays, but also with practitioner delays. The challenge is that
among the hundreds of patients with potential cancer symptoms
that every general practitioner sees each year, only eight of these
will actually have the disease. This review also suggests the need
for effective use of referral guidelines for general practitioners, as
well as better use of, and access to, diagnostic services.
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